Kaveeta Vasisht MD, PharmD, is the Associate Commissioner for Women’s Health at the U.S. Food and Drug Administration (FDA). She directs the FDA Office of Women’s Health (OWH), which serves to protect and advance the health of women through scientific programs, policy development, research, education, stakeholder collaboration, and outreach.
Dr. Vasisht leads efforts to advance regulatory science through understanding sex differences, promoting the inclusion of women and diversity in clinical trials, and establishing women’s health research priorities at FDA. Under her leadership OWH recently developed the Knowledge and News on Women’s Health Initiative, bringing broader awareness to conditions that not only impact women, but also highlighting how health conditions can affect women differently. In addition, she leads efforts to bridge important knowledge gaps on medication use in pregnancy and lactation.
Dr. Vasisht and OWH have received numerous FDA awards in recognition of their contributions.
Prior to her current role, she served as a Deputy Director in FDA’s Center for Drug Evaluation and Research (CDER) Office of Medical Policy and has extensive expertise in leading regulatory policy development.
She also provided clinical expertise on multidisciplinary teams in the review and evaluation of scientific data to make regulatory decisions on the safety and effectiveness of therapeutics during her tenure in CDER’s Office of New Drugs.
Dr. Vasisht is board-certified in both internal medicine and adult endocrinology. She completed her internal medicine and endocrinology fellowship training at the University of Chicago Hospitals, where she also served on the faculty. She also holds a Doctor of Pharmacy degree from Rutgers College of Pharmacy where she graduated from the Honors Research Program.